Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or Knee
Clinical trial NCT02697773 · COMPLETED
Trial details
- NCT number
- NCT02697773
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-21
- Primary completion
- 2017-12-05
- Enrollment
- 698
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.